FDA Approved: ERIBULIN MESYLATE — Original Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved an original (generic) application for Eribulin Mesylate from Gland Pharma Limited, authorizing the generic version of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Liposarcoma

Drugs mentioned

• ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

ORIG AP for ERIBULIN MESYLATE (ERIBULIN MESYLATE)